In light of recent events, anthrax has once again taken center stage in the world of science and the world in which we live. Because patients with anthrax may initially present to otolaryngology clinics, it is important for the otolaryngologist to know how to diagnose and treat this entity. This article will present current information on epidemiology, microbiology, pathogenesis/clinical manifestations, diagnosis, and treatment with a particular interest in the head and neck region.
Get full access to this article
View all access options for this article.
References
1.
LaforceF Marc. Pathogenesis and epidemiology of anthrax. In: RoseBD, editor. Up to date. Wellesley, MA:2001.
2.
DixonTCMeselsonMGuilleminJ et al. Anthrax. N Engl J Med1999;341:815–26.
LaforceF Marc. Clinical features and treatment of anthrax. In: Up To Date, RoseBD, editor. Up to date. Wellesley, MA:2001.
5.
SirisanthanaRNavachareonNTharaichitkulP et al. Outbreak of oral-oropharyngeal anthrax: An unusual manifestation of human infection with bacillus anthracis. Am J Trop Med Hyg1984;33:144–50.
6.
DoganayMAlmacAHanagasiR. Primary throat anthrax. A report of six cases. Scand J Infect Dis1986;18:415–9.
7.
InglesbyTVHendersonDABartlettJG et al. Anthrax as a biological weapon: Medical and public health management. JAMA1999;218:1735–45.
8.
MeselsonMGuilleminJHugh-JonesM et al. The Sverdlovsk anthrax outbreak of 1979. Science1994;266:1202–7.
9.
KhajehdehiP. Toxemic shock, hematuria, hypokalemia, and hypoproteinemia in a case of cutaneous anthrax. Mt Sinai J Med2001;68:213–5.
10.
KatzAM. Nasal anthrax in Boston. Pharos1995;58:48–9.
11.
ShafazandSDoyleRRuossS et al. Inhalational anthrax: Epidemiology, diagnosis, and management. Chest1999;116:1369–76.
12.
NavacharoenNSirisanthanaTNavacharoenW et al. Oropharyngeal anthrax. The Journal of Laryngology and Otology1985;99:1293–5.
13.
HailASRossiCALudwigGV et al. Comparison of noninvasive sampling sites for early detection of bacillus anthracis spores from rhesus monkeys after aerosol exposure. Military Medicine1999;164:833–7.
14.
LevinsonWJawetzE. Gram positive rods. In: Medical microbiology & immunology, 3rd edition. London; 1994. p. 81.
15.
ShlyakhovERubinsteinE. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis1996;15:242–5.
16.
RonaghyHAAzadehBKohoutE et al. Penicillin therapy of human cutaneous anthrax. Curr Ther Res1972;14:721.
17.
BrachmanPSGoldHPlotkinSA et al. Field evaluation of human anthrax vaccine. Am J Public Health1962;52:632–45.
18.
IvinsBEFellowsPPittML et al. Efficacy of standard human anthrax vaccine against bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull1996;87:125–6.
19.
MourezMKaneRSMogridgeJ et al. Designing a polyvalent inhibitor of anthrax toxin. Nature Biotechnology2001;19:958–61.
20.
WattersJWDewarKLehoczkyJ et al. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Current Biology2001;11:1503–11.
